Hitachi Chemical Co Ltd (4217.T)
Latest Key Developments (Source: Significant Developments)
Jan 31 (Reuters) - Hitachi Chemical Co Ltd <4217.T>::HITACHI CHEMICAL CO. LTD. TO ACQUIRE APCETH BIOPHARMA GMBH, EXPANDING GLOBAL FOOTPRINT OF ITS CELL AND GENE THERAPY CONTRACT DEVELOPMENT AND MANUFACTURING SERVICES.HITACHI CHEMICAL ADVANCED THERAPEUTICS SOLUTIONS - APCETH BIOPHARMA WILL JOIN HITACHI CHEMICAL'S PERCENT GLOBAL SERVICES PLATFORM. Full Article
March 13 (Reuters) - SanBio Co Ltd <4592.T>:Says co forms business alliance with Hitachi Chemical Co Ltd <<<4217.T>>> and its unit Hitachi Chemical Advanced Therapeutics Solutions, LCC, regarding manufacturing of SB623. Full Article
Jan 4(Reuters) - Kyowa Hakko Kirin Co Ltd <4151.T>:Says it sold 66.6 percent stake in wholly owned unit Kyowa Medex Co., Ltd., to Hitachi Chemical Company, Ltd <<<4217.T>>>, on Jan. 4 . Full Article
Sept 29(Reuters) - Kyowa Hakko Kirin Co Ltd <4151.T>:Says it will sell a part of stake in wholly owned unit Kyowa Medex Co., Ltd., to Hitachi Chemical Company, Ltd.<<<4217.T>>>.Price undetermined .Says the company will cut stake in Kyowa Medex to 33.4 percent .Transaction date on Jan. 4, 2018. Full Article
TOKYO Japan's Hitachi Ltd has started the formal process for the sale of its $5.6 billion chemical unit with initial bids due in August, people familiar with the matter said, a deal that is expected to draw interest from global private-equity firms.